Renewal of NCIB Allows Continued Repurchase of Shares for CancellationUp to 11.7 Million Shares May be Purchased for CancellationPrimary NCIB Goal Remains Maintaining a Constant YOY Outstanding Share CountAmerigo’s Capital Return Strategy Includes Quarterly Dividends, Performance Dividends & NCIB VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce that it has received approval from the Toronto Stoc ...

VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Leviathan Metals Corp. (“Leviathan” or the “Company”) (LVX – TSXV, LVXFF – OTC, 0GP – FSE) is pleased to announce closing of its previously announced transaction (the “Transaction”) with Cura Exploration Botswana Corp. (“Cura”). The Transaction was carried out by way of an amalgamation under the laws of the Province of British Columbia pursuant to the terms of an amalgamation agreement dated September 11, 2025 (as amended on October 31, 2025) be ...

RENO, Nev., Nov. 28, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries®, brings to market the Battle Born® Power Station Series, the company’s debut line of all-in-one portable power stations designed for demanding professional and off-grid applications. The Battle Born® Power Station 3000 and Battle Born® Power Station Pro 5000 expand the Company’s product portfolio into ful ...

Core Insights - TG Therapeutics, Inc. will participate in the 8th Annual Evercore Healthcare Conference from December 2-4, 2025, with a fireside chat scheduled for December 2, 2025, at 12:30 PM ET [1] Company Overview - TG Therapeutics is a fully integrated, commercial-stage biopharmaceutical company focused on developing and commercializing novel treatments for B-cell diseases [3] - The company has received FDA approval for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease [3] - BRIUMVI has also received approval from several regulatory agencies outside the U.S. for treating adult patients with relapsing multiple sclerosis who have active disease defined by clinical or imaging features [3]

WINNIPEG, Manitoba, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced its third quarter 2025 financial results. Third Quarter 2025 Financial Highlights (Comparatives exclude discontinued STEM Animal Health “STEM” Operations): Total revenue for the three months ended September 30, 2025 was $8,499 compared to $1,282,698 in the three months ended September 30, 2024. The vast majority of revenue recorded in the comparative quarter was relat ...

Core Viewpoint - Pet Valu Holdings Ltd. has announced the acceptance of its notice to renew its normal course issuer bid (NCIB), allowing the company to repurchase up to 3,449,181 common shares, approximately 5% of its outstanding shares [1][2]. Group 1: NCIB Details - The NCIB allows Pet Valu to purchase up to 34,220 common shares on any trading day, representing 25% of the average daily trading volume of 136,880 shares over the past six months [2]. - The repurchase period for the NCIB will commence on December 2, 2025, and will continue until the earliest of December 1, 2026, the date the maximum number of shares is acquired, or the date of termination notice to the TSX [2][3]. - Purchases will be conducted in accordance with TSX rules, at market prices or other permitted prices, through open market transactions or other means allowed by securities regulatory authorities [3]. Group 2: Automatic Share Purchase Plan - Pet Valu has entered into an automatic share purchase plan with a designated broker, allowing the broker to purchase shares during trading blackout periods, subject to price limitations and TSX rules [4]. - The company can instruct the broker for specific purchases and can suspend or terminate the plan, ensuring compliance with insider trading policies [4]. Group 3: Shareholder Value - The NCIB is expected to provide the company with additional flexibility to manage capital and enhance shareholder value [5]. Group 4: Previous NCIB Performance - Under the previous NCIB, which started on December 2, 2024, and ends on December 1, 2025, Pet Valu received approval to purchase up to 3,572,004 common shares and has repurchased 1,503,373 shares at an average price of approximately $26.54 per share [6]. Group 5: Company Overview - Pet Valu is Canada's leading retailer of pet food and supplies, operating over 800 locations and offering more than 10,000 products, including exclusive and award-winning brands [7].

Core Insights - High Arctic Overseas Holdings Corp. reported its third quarter 2025 financial results, highlighting a significant decline in revenue and increased operational losses due to reduced activity in Papua New Guinea (PNG) [2][6][23] Financial Performance - Revenue for Q3 2025 was $1,983 thousand, down from $2,891 thousand in Q3 2024, reflecting a decrease in operational activities [10][16] - The net loss for Q3 2025 was $1,330 thousand, compared to a loss of $1,421 thousand in Q3 2024 [10][16] - Adjusted EBITDA loss increased to $741 thousand in Q3 2025 from a loss of $365 thousand in Q3 2024, primarily due to the planned wind down of customer project activities [6][10] - Cash used in operating activities was $800 thousand in Q3 2025, contrasting with cash generated of $1,219 thousand in Q3 2024 [19][22] Business Strategy and Outlook - The company is focusing on diversifying its service offerings, particularly in equipment rental and manpower services, while also establishing a new Fire Services business [2][6][25] - High Arctic remains optimistic about future major projects in PNG, despite current subdued market conditions, and is preparing for potential increases in service inquiries [2][24] - The outlook for the remainder of 2025 indicates continued reliance on manpower and rental services, with expectations of a decline in these activities as certain projects conclude [23][24] Operational Highlights - The company has maintained a strong working capital position of over $19 million, despite the operational challenges faced [6][10] - Drilling activities have been consistent with previous quarters, with Rig 103 suspended and Rigs 115 and 116 cold stacked [6][17] - The establishment of the Fire Services business is seen as a strategic move to enhance revenue streams in the future [6][23] Market Context - PNG is viewed as a region with substantial natural resource deposits, and the company is strategically positioned to benefit from upcoming large-scale projects, including the anticipated Papua-LNG project [25][26][27] - The company aims to leverage its existing relationships and capabilities to capitalize on future opportunities in the oil and gas sector [27][28]

Core Viewpoint - PyroGenesis Inc. has successfully closed a non-brokered private placement, raising a total of $5,226,083 through the sale of 14,185,969 units, which includes two unit groups [1][4]. Group 1: Private Placement Details - The private placement consisted of two unit groups, with the first group selling 5,555,556 units at a price of $0.63 per unit, generating gross proceeds of $3,500,000 [2]. - The second tranche of the second unit group issued 4,520,414 units at a price of $0.20 per unit, resulting in gross proceeds of $904,083, in addition to the first tranche of 4,110,000 units that raised $822,000 [3]. - In total, the two unit groups accounted for 14,185,969 units sold for gross proceeds of $5,226,083 [4]. Group 2: Use of Proceeds and Regulatory Approval - The proceeds from the private placement will be utilized for working capital and general corporate purposes [5]. - The private placement has received conditional approval from the TSX, pending final approval and customary closing conditions [5]. Group 3: Unit Group Structure - Each unit in the first group consists of one common share and one warrant, priced at $0.63, with the warrant allowing the purchase of a common share at $0.28 for 48 months [8]. - Each unit in the second group consists of one common share and one warrant, priced at $0.20, with the warrant allowing the purchase of a common share at $0.40 for 24 months [8].

Core Viewpoint - Aurora Mobile Limited has partnered with Beijing Fenbeitong Technology Co., Ltd. to enhance messaging efficiency and user engagement through the integration of Aurora Mobile's JPush solution with Fenbeitong's core app [1][6]. Group 1: Partnership Details - The partnership aims to improve user experience by leveraging advanced technology for better messaging efficiency [1][6]. - Fenbeitong, a leading enterprise expense management platform, seeks to provide real-time updates and notifications to its large user base [2][6]. Group 2: Technology Integration - JPush supports multiple operating systems and messaging channels, ensuring consistent notifications across various devices [3][4]. - The integration of JPush has established a stable and intelligent messaging hub for Fenbeitong, enhancing user engagement and retention [5][6]. Group 3: User Experience Enhancement - JPush's features allow for personalized messaging based on user behavior, improving message relevance and click-through rates [4][5]. - The collaboration is expected to deliver smarter and more transparent expense management experiences for enterprise users [7]. Group 4: Company Background - Aurora Mobile, founded in 2011, is a leading provider of customer engagement and marketing technology services in China, focusing on stable messaging solutions for enterprises [8].

Core Points - Sparinvest S.A. has announced the resumption of net asset value calculations for specific departments within Sparinvest SICAV, following the rules of Nasdaq Copenhagen [1] - Trading suspension for the affected departments has been lifted [1] Fund Details - The following departments are included in the resumption: - European Value EUR R (ISIN: LU0264920413, Order Book Code: SSIEUVEURR) - Responsible Corporate Bonds IG EUR R (ISIN: LU0264925727, Order Book Code: SSIRCPEURR) - Responsible Corporate Bonds DKK R (ISIN: LU2703611538, Order Book Code: SSIRCBDKKR) - Long Danish Bonds DKK R (ISIN: LU0138507396, Order Book Code: SSILDBDKKR) - Global Convertible Bonds EUR R (ISIN: LU1438960566, Order Book Code: SSIGCBEURR) - Global Convertible Bonds DKK R (ISIN: LU2703611454, Order Book Code: SSIGCBDKKR) - Value Bonds - Short Dated High Yield EUR R (ISIN: LU1599093520, Order Book Code: SSIGSDHYEURR) - Global Short Dated High Yield DKK R (ISIN: LU2703611298, Order Book Code: SSIGSDHYDKKR) - Value Bonds - Global Ethical High Yield EUR R (ISIN: LU1735613934, Order Book Code: SSIGEHYEURR) - Value Bonds - Global Ethical High Yield DKK R H (ISIN: LU1735614155, Order Book Code: SSIGEHYDKKRH) [2] - Other departments mentioned in previous announcements remain under suspension [2] Communication - The company has expressed regret for the delay and provided contact information for inquiries related to the announcement [3]